Nephros (NEPH) Receivables - Net (2010 - 2026)

Nephros has reported Receivables - Net for 17 years, with the latest figure at $4.1 million in Q2 2026.

• On a quarterly basis, Receivables - Net rose 100.78% year-over-year to $4.1 million in Q2 2026; TTM through Jun 2026 was $4.1 million, a 100.78% increase from a year earlier, with the FY2025 full-year figure at $2.4 million, up 35.54% from the prior year.
• Receivables - Net was $4.1 million for Q2 2026 at Nephros, up from $3.5 million in the prior quarter.
• The five-year high for Receivables - Net was $4.1 million in Q2 2026, with the low at $1.3 million in Q4 2022.
• Average Receivables - Net over 5 years is $2.0 million, with a median of $1.8 million recorded in 2024.
• The sharpest annual moves came in 2023 and 2026: Receivables - Net declined 25.94% in 2023, then jumped 100.78% in 2026.
• Over 5 years, Receivables - Net stood at $1.3 million in 2022, then rose by 16.33% to $1.5 million in 2023, then advanced by 19.05% to $1.8 million in 2024, then surged by 35.54% to $2.4 million in 2025, then surged by 69.68% to $4.1 million in 2026.
• The last three Receivables - Net figures came in at $4.1 million (Q2 2026), $3.5 million (Q1 2026), and $2.4 million (Q4 2025), per Business Quant data.